JP2007516181A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007516181A5 JP2007516181A5 JP2006517573A JP2006517573A JP2007516181A5 JP 2007516181 A5 JP2007516181 A5 JP 2007516181A5 JP 2006517573 A JP2006517573 A JP 2006517573A JP 2006517573 A JP2006517573 A JP 2006517573A JP 2007516181 A5 JP2007516181 A5 JP 2007516181A5
- Authority
- JP
- Japan
- Prior art keywords
- immune composition
- immune
- composition
- composition according
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001282 polysaccharide Polymers 0.000 claims 10
- 239000005017 polysaccharide Substances 0.000 claims 10
- 150000004676 glycans Chemical class 0.000 claims 9
- 229960005486 vaccine Drugs 0.000 claims 5
- 102000014914 Carrier Proteins Human genes 0.000 claims 4
- 108010078791 Carrier Proteins Proteins 0.000 claims 4
- 241000991587 Enterovirus C Species 0.000 claims 4
- 201000005702 Pertussis Diseases 0.000 claims 4
- 206010043376 Tetanus Diseases 0.000 claims 4
- 206010013023 diphtheria Diseases 0.000 claims 4
- 230000003053 immunization Effects 0.000 claims 3
- 238000002649 immunization Methods 0.000 claims 3
- 241000709701 Human poliovirus 1 Species 0.000 claims 1
- 241000709704 Human poliovirus 2 Species 0.000 claims 1
- 241000709727 Human poliovirus 3 Species 0.000 claims 1
- 241000921898 Neisseria meningitidis serogroup A Species 0.000 claims 1
- IBVAQQYNSHJXBV-UHFFFAOYSA-N adipic acid dihydrazide Chemical group NNC(=O)CCCCC(=O)NN IBVAQQYNSHJXBV-UHFFFAOYSA-N 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 229960003983 diphtheria toxoid Drugs 0.000 claims 1
- 230000001900 immune effect Effects 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48092503P | 2003-06-23 | 2003-06-23 | |
| PCT/US2004/020121 WO2005000345A2 (en) | 2003-06-23 | 2004-06-23 | Immunization method against neisseria meningitidis serogroups a and c |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011004664A Division JP2011074087A (ja) | 2003-06-23 | 2011-01-13 | 髄膜炎菌血清群ａおよびｃに対する免疫方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007516181A JP2007516181A (ja) | 2007-06-21 |
| JP2007516181A5 true JP2007516181A5 (cg-RX-API-DMAC10.html) | 2007-08-16 |
Family
ID=33551955
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006517573A Pending JP2007516181A (ja) | 2003-06-23 | 2004-06-23 | 髄膜炎菌血清群ａおよびｃに対する免疫方法 |
| JP2011004664A Pending JP2011074087A (ja) | 2003-06-23 | 2011-01-13 | 髄膜炎菌血清群ａおよびｃに対する免疫方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011004664A Pending JP2011074087A (ja) | 2003-06-23 | 2011-01-13 | 髄膜炎菌血清群ａおよびｃに対する免疫方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20050019337A1 (cg-RX-API-DMAC10.html) |
| EP (2) | EP1644036A2 (cg-RX-API-DMAC10.html) |
| JP (2) | JP2007516181A (cg-RX-API-DMAC10.html) |
| AU (2) | AU2004251742A1 (cg-RX-API-DMAC10.html) |
| BR (1) | BRPI0411875A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2530434A1 (cg-RX-API-DMAC10.html) |
| MX (1) | MXPA05014171A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2005000345A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
| SI1740217T1 (sl) | 2004-04-30 | 2011-10-28 | Novartis Ag | Konjugirano meningokokno cepljenje |
| GB0500787D0 (en) | 2005-01-14 | 2005-02-23 | Chiron Srl | Integration of meningococcal conjugate vaccination |
| GB0505518D0 (en) | 2005-03-17 | 2005-04-27 | Chiron Srl | Combination vaccines with whole cell pertussis antigen |
| KR101408113B1 (ko) | 2005-06-27 | 2014-06-16 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 백신 제조 방법 |
| KR20150038626A (ko) | 2006-03-17 | 2015-04-08 | 더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카 에즈 레프리젠티드 바이 더 세크러테리 오브 더 디파트먼트 오브 헬스 앤드 휴먼 서비시즈 | 복합 다가 면역원성 콘쥬게이트의 제조 방법 |
| NZ572054A (en) * | 2006-03-22 | 2011-12-22 | Novartis Ag | Regimens for immunisation with meningococcal conjugates |
| US10828361B2 (en) | 2006-03-22 | 2020-11-10 | Glaxosmithkline Biologicals Sa | Regimens for immunisation with meningococcal conjugates |
| US8414899B2 (en) | 2006-04-11 | 2013-04-09 | Yeda Research And Development Co. Ltd. | Vaccines comprising multimeric HSP60 peptide carriers |
| AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
| PT2608805T (pt) | 2010-08-23 | 2017-09-11 | Wyeth Llc | Formulações estáveis de antigénios de rlp2086 de neisseria meningitidis |
| CN103096920B (zh) | 2010-09-10 | 2016-03-23 | 惠氏有限责任公司 | 脑膜炎奈瑟球菌orf2086抗原的非脂质化变体 |
| JP5925342B2 (ja) | 2012-03-09 | 2016-05-25 | ファイザー・インク | 髄膜炎菌（Ｎｅｉｓｓｅｒｉａｍｅｎｉｎｇｉｔｉｄｉｓ）組成物およびその方法 |
| SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
| SG11201407440WA (en) | 2012-05-22 | 2014-12-30 | Novartis Ag | Meningococcus serogroup x conjugate |
| ES2685894T3 (es) | 2013-03-08 | 2018-10-15 | Pfizer Inc. | Polipéptidos de fusión inmunogénicos |
| CA2923129C (en) | 2013-09-08 | 2020-06-09 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| IL312865B2 (en) | 2013-09-11 | 2025-06-01 | Eagle Biologics Inc | Liquid protein formulations containing viscosity-lowering agents |
| CN106999510B (zh) * | 2014-10-01 | 2021-04-30 | 伊格尔生物制品有限公司 | 含有粘度降低剂的多糖和核酸制剂 |
| KR20170103009A (ko) | 2015-02-19 | 2017-09-12 | 화이자 인코포레이티드 | 나이세리아 메닌지티디스 조성물 및 그의 방법 |
| IL303108B2 (en) | 2017-01-31 | 2024-07-01 | Pfizer | NEISSERIA MENINGITIDIS preparations and methods therefor |
| EP4034157A1 (en) | 2019-09-27 | 2022-08-03 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4356170A (en) | 1981-05-27 | 1982-10-26 | Canadian Patents & Development Ltd. | Immunogenic polysaccharide-protein conjugates |
| US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
| US4619828A (en) * | 1982-07-06 | 1986-10-28 | Connaught Laboratories, Inc. | Polysaccharide exotoxoid conjugate vaccines |
| US4644059A (en) | 1982-07-06 | 1987-02-17 | Connaught Laboratories, Inc. | Haemophilus influenzae B polysaccharide-diptheria toxoid conjugate vaccine |
| US5153312A (en) | 1990-09-28 | 1992-10-06 | American Cyanamid Company | Oligosaccharide conjugate vaccines |
| US5422427A (en) | 1991-09-17 | 1995-06-06 | The United States Of America As Represented By The United States Department Of Health And Human Services | Pneumococcal fimbrial protein A |
| FR2682388B1 (fr) | 1991-10-10 | 1995-06-09 | Pasteur Merieux Serums Vacc | Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal. |
| US5445817A (en) | 1992-08-21 | 1995-08-29 | The United States Of America As Represented By The Department Of Health And Human Services | Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines |
| US5425946A (en) | 1992-08-31 | 1995-06-20 | North American Vaccine, Inc. | Vaccines against group C Neisseria meningitidis |
| US5965714A (en) * | 1997-10-02 | 1999-10-12 | Connaught Laboratories, Inc. | Method for the covalent attachment of polysaccharides to protein molecules |
| GB9806456D0 (en) * | 1998-03-25 | 1998-05-27 | Smithkline Beecham Biolog | Vaccine composition |
| US6146902A (en) | 1998-12-29 | 2000-11-14 | Aventis Pasteur, Inc. | Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions |
| EP2279748A1 (en) * | 2000-06-29 | 2011-02-02 | SmithKline Beecham Biologicals S.A. | Multivalent vaccine composition |
| GB0108364D0 (en) * | 2001-04-03 | 2001-05-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
| AP1897A (en) * | 2001-01-23 | 2008-10-10 | Aventis Pasteur | Multivalent Meningococcal polysaccharide-Protein Conjugate Vaccine. |
| AU2002309706A1 (en) * | 2001-05-11 | 2002-11-25 | Aventis Pasteur, Inc. | Novel meningitis conjugate vaccine |
| EP2191844B1 (en) * | 2003-01-30 | 2014-03-05 | Novartis AG | Injectable vaccines against multiple meningococcal serogroups |
-
2004
- 2004-06-23 MX MXPA05014171A patent/MXPA05014171A/es active IP Right Grant
- 2004-06-23 EP EP04755949A patent/EP1644036A2/en not_active Withdrawn
- 2004-06-23 BR BRPI0411875-8A patent/BRPI0411875A/pt not_active IP Right Cessation
- 2004-06-23 CA CA002530434A patent/CA2530434A1/en not_active Abandoned
- 2004-06-23 US US10/876,290 patent/US20050019337A1/en not_active Abandoned
- 2004-06-23 AU AU2004251742A patent/AU2004251742A1/en not_active Abandoned
- 2004-06-23 EP EP10183385A patent/EP2364725A3/en not_active Withdrawn
- 2004-06-23 WO PCT/US2004/020121 patent/WO2005000345A2/en not_active Ceased
- 2004-06-23 JP JP2006517573A patent/JP2007516181A/ja active Pending
-
2010
- 2010-11-23 AU AU2010246390A patent/AU2010246390A1/en not_active Withdrawn
-
2011
- 2011-01-13 JP JP2011004664A patent/JP2011074087A/ja active Pending